Log in

TFX TELEFLEX INC NYSE · United States

TELEFLEX INC (TFX) news TFX offering news

Latest TELEFLEX INC news

  1. Debt Financing

    Teleflex enters new credit agreement with JPMorgan Chase as agent

    The credit agreement names JPMorgan Chase Bank, N.A. as administrative agent. The company's Form 8-K describes a revolver and two term loan facilities that refinance its earlier agreement.

TELEFLEX INC annual financials

LineFY2025FY2024
Revenue$1.99 billion$1.70 billion
Research and development$144.8 million$109.0 million
Net income (loss)-$905.6 million$69.7 million
Cash and equivalents$378.6 million$247.9 million

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $300.2 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about TELEFLEX INC

Has TELEFLEX INC raised money recently?

Our latest story on this, dated Jun 1, 2026: "Teleflex prices $500.0 million of 5.875% senior notes due 2032". The story links the filing or release it is based on. Read the story.

What is the ticker symbol of TELEFLEX INC?

TELEFLEX INC trades under the ticker TFX on NYSE.

Where is TELEFLEX INC listed?

TELEFLEX INC is listed on NYSE.

Which country or territory is TELEFLEX INC listed under?

Our directory records TELEFLEX INC under United States.

Does aibio.space cover TELEFLEX INC?

aibio.space lists TELEFLEX INC among 2,820 public biotech companies and publishes its news here as stories appear.

What was TELEFLEX INC's revenue last year?

$1.99 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is TELEFLEX INC profitable?

TELEFLEX INC reported a net loss of $905.6 million for the fiscal year ended Dec 31, 2025, per its annual report to the SEC.

How much does TELEFLEX INC spend on research and development?

$144.8 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does TELEFLEX INC have?

$300.2 million in cash at Jun 30, 2026, per its 10-Q.

What is the latest TELEFLEX INC (TFX) stock news?

Our latest story on TELEFLEX INC, dated Jun 1, 2026: "Teleflex prices $500.0 million of 5.875% senior notes due 2032". Teleflex will use the proceeds, with cash on hand, to redeem its outstanding 4.625% Senior Notes due 2027. The notes are being sold in a private offering. Source.

Does TELEFLEX INC have debt, a term loan or convertible notes?

Our latest debt story, dated Jun 1, 2026: "Teleflex prices $500.0 million of 5.875% senior notes due 2032". Teleflex will use the proceeds, with cash on hand, to redeem its outstanding 4.625% Senior Notes due 2027. The notes are being sold in a private offering. Source.

How can I follow TELEFLEX INC (TFX) news?

Press Follow on this page to add TELEFLEX INC to your Following list, or subscribe to the aibio.space newsletter. We have published 2 stories naming TELEFLEX INC so far, in Debt Financing.

Investor discussion: TELEFLEX INC

Members talk about TELEFLEX INC (TFX). Reader posts, not aibio.space reporting, and not investment advice.

Rules
  1. Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
  2. Say whether you hold the stock. Every post states long, short or no position.
  3. No paid or sponsored posts. Do not post for anyone who pays or rewards you.
  4. No buy or sell calls and no price targets.
  5. No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
  6. No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Capital-markets timeline

Financings, listing notices, splits, legal actions and other investor events at TELEFLEX INC, newest first. Each line links the filing it comes from.

  1. Mergers

    Reported completing an acquisition or a sale of assets. SEC Form 8-K (Items 2.01,7.01,9.01). Source

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NYSE:TFX on TradingView.

Listing details

TELEFLEX INC is a public biotech or pharmaceutical company listed on NYSE under the ticker TFX, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Company
TELEFLEX INC
Ticker
TFX
Listing
NYSE
Country or territory
United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction

aibio.space

Full desks

Every other company has a starter desk. Search above to open one.

Settings

Appearance
Text size
Motion

Stops the news strip and the share rollers.

Your choices are saved in this browser only.

Free membership

Read aibio.space in full, free

Subscribe with your email address to read every story, company desk and profile in full. It costs nothing. In return, you agree that we may email you, including offers. One click to unsubscribe.

No card, no password. With email, we send one message to confirm your address first. With Google or Facebook we receive only your email address. Not investment advice.